Five New York doctors charged with taking kickbacks from Insys

Image
Reuters NEW YORK
Last Updated : Mar 17 2018 | 3:15 AM IST

By Brendan Pierson

NEW YORK (Reuters) - Federal prosecutors on Friday brought charges against five New York doctors accused of taking kickbacks from Insys Therapeutics Inc in exchange for prescribing the company's potent fentanyl-based cancer pain medication.

An indictment filed in Manhattan federal court said Gordon Freedman, Jeffrey Goldstein, Todd Schlifstein, Dialecti Voudouris and Alexandru Burducea received fees from Insys to participate as speakers in sham educational events.

Prosecutors also said that two former Insys employees who were first charged in 2016 in connection with the scheme, Jonathan Roper and Fernando Serrano, had secretly pleaded guilty and become cooperating witnesses.

The five doctors were arrested on Friday morning and face charges including that they violated the federal anti-kickback law and conspired to commit fraud. They pleaded not guilty on Friday before U.S. Magistrate Judge Sarah Netburn in Manhattan and were released on bail.

"We look forward to resolution of the charges," said Nicholas Kaizer, a lawyer for Burducea, after the court hearing. The other defendants and their lawyers had no immediate comment.

The case is the latest in a series of medical practitioners and former Insys executives and employees facing criminal charges related to Subsys, the company's potentially addictive fentanyl-based spray.

Federal prosecutors in Boston have accused seven former executives and managers at Insys, including billionaire founder John Kapoor, of participating in a scheme to bribe doctors to prescribe Subsys and to defraud insurers into paying for it. The seven have pleaded not guilty.

Insys has said it may need to pay at least $150 million towards part of a settlement with the U.S. Justice Department.

Chandler, Arizona-based Insys did not respond to a request for comment.

According to Friday's indictment, the five doctors participated in Insys' speaker programs, which were in reality social gatherings at high-end restaurants.

They earned kickbacks ranging from $68,000 and $308,000 and were among the top 20 prescribers of Subsys nationwide at some point during the scheme, prosecutors said.

In 2013 Goldstein and Schlifstein went to a strip club with Roper, an Insys sales manager; Serrano, an Insys sales representative; and an unnamed Insys executive, and Insys covered the $4,100 bill, which included lap dances, the indictment said.

Freedman, 57; Voudouris, 47; and Burducea, 41 have all been affiliated with New York's Mount Sinai hospital, according to the hospital's website. Schlifstein, 49, and Goldstein, 48, co-owned a private medical office on Manhattan's Upper East Side.

Mount Sinai could not immediately be reached for comment.

(Additional reporting by Nate Raymond in Boston; editing by Bernadette Baum and Rosalba O'Brien)

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 17 2018 | 3:07 AM IST

Next Story